Jumawid, Jhonkirth A.
HRN: 27-08-35 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/05/2025
CO-AMOXICLAV 625MG (TAB)
05/05/2025
05/12/2025
PO
625mg
BID
S/P Wound Suturing
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes